118. Questions in Bacteremia
Friday, October 6, 2017: 8:30 AM-10:00 AM
Room: 06CF

Learning Objectives:

At the conclusion of this session, participants will be able to:

  • explain the role of source control in the management of bacteremia
  • discuss the impact of antibacterial resistance patterns on patients outcomes after bacteremia
  • describe the role of combination therapy in the management of bacteremia

Target Audience: Academicians, Clinicians, Epidemiologists, Fellows, Healthcare workers, HIV clinicians, HIV specialists, Hospital epidemiologists, Infection preventionists, Infectious diseases pediatricians, Infectious diseases physicians, Investigators, Microbiologists, Nurses, Pharmacists, Researchers, Scientists

Tracks: Adult ID

Moderators:  David Van Duin, MD, PhD, University of North Carolina and Federico Perez, MD, MS, Louis Stokes Cleveland VA Medical Center

8:30 AM
Role of Source Control in Bacteremia: What is the Data?
Belinda Ostrowsky, MD, MPH, FIDSA, FSHEA

9:45 AM

CME Credits: Maximum of 1.50 hours of AMA PRA Category 1 Credit™

ACPE Credits: ACPE 1.5 knowledge-based contact hours of pharmacy CE

ACPE Number: 0221-9999-17-270-L01-P


D. Van Duin, Astellas: Scientific Advisor , Consulting fee
Achaogen: Scientific Advisor , Consulting fee
Allergan: Scientific Advisor , Consulting fee
MedImmune: Scientific Advisor , Consulting fee
Shionogi: Scientific Advisor , Consulting fee

F. Perez, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 4th with the exception of research findings presented at the IDWeek press conferences.